Wall Street's major averages rebounded strongly on Friday, a day after stocks closed in correction territory as President ...

Wall Street's major averages trade mixed on Wednesday as retail inflation slowed more than expected in February along with ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

TVB-3567 is the Company’s second fatty acid synthase (FASN) inhibitor First-in-human Phase 1 trial initiation planned in 2025 ...

A quarter century later, the Nasdaq is once again in the midst of a new technical revolution with the emergence of AI. Click ...

(RTTNews) - Humacyte, Inc. (HUMA), a biotechnology company, Tuesday announced its plan to file an Investigational New Drug or IND application ... reflect those of Nasdaq, Inc. Founded in the ...

Jan. 28, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical ... with autoimmune diseases. Today, with the FDA’s clearance of our IND, that vision has become a ...

The main indexes lost steam as the session wore on, though the tech-heavy Nasdaq Composite held on ... straight to your e-mail. Sign up Today's data "provided confirmation that the Federal Reserve ...

Stock index futures climbed on Wednesday as Commerce Secretary Howard Lutnick stoked hopes for a tariff-relief deal. Tariffs are triggering volatility. Don’t wait for tomorrow’s headlines—get the ...

Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that portfolio company PharmNovo received positive feedback regarding its most advanced drug candidate, PN6047, in a pre-IND meeting ...